The table below shows Bionano Genomics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$6.69M
$7.37M
$6.73M
$6.46M
$6.07M
$7.77M
Cost of revenue
$3.44M
$4.00M
$3.26M
$3.52M
$14.52M
$5.19M
Gross profit
-
-
-
-
-
-
R&D
$3.14M
$2.84M
$2.93M
$2.37M
$4.72M
$6.83M
BNGO annual revenue (10-K history)
Bionano Genomics, Inc. reported annual revenue of $28.51M for fiscal year 2025. That is down 7.4% from $30.78M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $9.51M (FY 2017) to $28.51M. Figures come from the company's audited annual reports as filed with the SEC.